Biostage, Inc.
BSTG · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $1,319 | $786 | $1,728 | $2,486 |
| + Debt | $116 | $145 | $172 | $199 |
| Enterprise Value | – | – | – | – |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$112 | -$302 | -$33 | -$257 |
| % Margin | – | – | – | – |
| EBITDA | -$1,673 | -$2,150 | -$1,715 | -$637 |
| % Margin | – | – | – | – |
| Net Income | -$1,700 | -$1,823 | -$1,659 | -$1,344 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.11 | -0.1 | -0.07 |
| % Growth | 9.1% | -10% | -42.9% | – |
| Operating Cash Flow | -$1,465 | -$941 | -$758 | $3,428 |
| Capital Expenditures | $0 | $0 | $0 | $11 |
| Free Cash Flow | -$1,465 | -$941 | -$758 | $3,439 |